399 related articles for article (PubMed ID: 1423635)
1. Regulation of the specific DNA binding function of p53.
Hupp TR; Meek DW; Midgley CA; Lane DP
Cell; 1992 Nov; 71(5):875-86. PubMed ID: 1423635
[TBL] [Abstract][Full Text] [Related]
2. Activation of the cryptic DNA binding function of mutant forms of p53.
Hupp TR; Meek DW; Midgley CA; Lane DP
Nucleic Acids Res; 1993 Jul; 21(14):3167-74. PubMed ID: 8341590
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
Hupp TR; Lane DP
Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
[TBL] [Abstract][Full Text] [Related]
4. Precise characterisation of monoclonal antibodies to the C-terminal region of p53 protein using the PEPSCAN ELISA technique and a new non-radioactive gel shift assay.
Pospísilová S; Brázda V; Amrichová J; Kamermeierová R; Palecek E; Vojtesek B
J Immunol Methods; 2000 Apr; 237(1-2):51-64. PubMed ID: 10725451
[TBL] [Abstract][Full Text] [Related]
5. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of DNA binding and in vitro transcriptional activities dependent on the C terminus of P53 proteins.
Kaku S; Albor A; Kulesz-Martin M
Biochem Biophys Res Commun; 2001 Jan; 280(1):204-11. PubMed ID: 11162500
[TBL] [Abstract][Full Text] [Related]
7. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
Rolley N; Milner J
Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.
Prowald A; Schuster N; Montenarh M
FEBS Lett; 1997 May; 408(1):99-104. PubMed ID: 9180277
[TBL] [Abstract][Full Text] [Related]
9. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
Hansen S; Hupp TR; Lane DP
J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
[TBL] [Abstract][Full Text] [Related]
10. Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies.
Brázda V; Paleĉek J; Pospísilová S; Vojtêsek B; Paleĉek E
Biochem Biophys Res Commun; 2000 Jan; 267(3):934-9. PubMed ID: 10673394
[TBL] [Abstract][Full Text] [Related]
11. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
Müller E; Boldyreff B; Scheidtmann KH
Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
[TBL] [Abstract][Full Text] [Related]
12. Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70.
Hansen S; Midgley CA; Lane DP; Freeman BC; Morimoto RI; Hupp TR
J Biol Chem; 1996 Nov; 271(48):30922-8. PubMed ID: 8940078
[TBL] [Abstract][Full Text] [Related]
13. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.
Jayaraman J; Prives C
Cell; 1995 Jun; 81(7):1021-9. PubMed ID: 7600571
[TBL] [Abstract][Full Text] [Related]
14. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.
Graeber TG; Peterson JF; Tsai M; Monica K; Fornace AJ; Giaccia AJ
Mol Cell Biol; 1994 Sep; 14(9):6264-77. PubMed ID: 8065358
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.
Takenaka I; Morin F; Seizinger BR; Kley N
J Biol Chem; 1995 Mar; 270(10):5405-11. PubMed ID: 7534296
[TBL] [Abstract][Full Text] [Related]
17. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
Meek DW; Simon S; Kikkawa U; Eckhart W
EMBO J; 1990 Oct; 9(10):3253-60. PubMed ID: 2145148
[TBL] [Abstract][Full Text] [Related]
18. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
Zhang W; Guo XY; Deisseroth AB
Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
[TBL] [Abstract][Full Text] [Related]
19. Recognition of DNA modified by antitumor cisplatin by "latent" and "active" protein p53.
Fojta M; Pivonkova H; Brazdova M; Kovarova L; Palecek E; Pospisilova S; Vojtesek B; Kasparkova J; Brabec V
Biochem Pharmacol; 2003 Apr; 65(8):1305-16. PubMed ID: 12694871
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
Müller E; Scheidtmann KH
Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
